Sign Up Today and Learn More About Atavistik Bio Stock
Invest in or calculate the value of your shares in Atavistik Bio or other pre-IPO companies through EquityZen's platform.
Atavistik Bio Stock
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
About Atavistik Bio Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Science and Engineering
Atavistik Bio Press Mentions
Stay in the know about the latest news on Atavistik Bio
Two New Takes on Making a Type of Targeted Cancer Therapy Even Better
medcitynews • Apr 16, 2026
Next-generation allosteric modulators: A glance at the biotech pipeline in 2026
labiotech • Apr 01, 2026
Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies
medcitynews • Mar 08, 2026
美国临床前药物研发服务提供商Atavistik Bio获得4000万美元B轮融资
ifastdata • Mar 07, 2026
Financings for March 6, 2026
bioworld • Mar 07, 2026
Atavistik Bio Management
Leadership team at Atavistik Bio
Co-founder
Ralph J DeBerardinis
Co-founder
Jared Rutter
Join now and verify your accreditation status to gain access to:
- Atavistik Bio Current Valuation
- Atavistik Bio Stock Price
- Atavistik Bio Management
- Available deals in Atavistik Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Atavistik Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Atavistik Bio Revenue and Financials
- Atavistik Bio Highlights
- Atavistik Bio Business Model
- Atavistik Bio Risk Factors
- Atavistik Bio Research Report from SACRA Research
Trading Atavistik Bio Stock
How to invest in Atavistik Bio stock?
Accredited investors can buy pre-IPO stock in companies like Atavistik Bio through EquityZen funds. These investments are made available by existing Atavistik Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Atavistik Bio stock?
Shareholders can sell their Atavistik Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."